{"id":"nono-42","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3656161","moleculeType":"Small molecule","molecularWeight":"455.96"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug releases or facilitates the production of nitric oxide, a signaling molecule that plays key roles in vasodilation, anti-inflammatory responses, and cellular regulation. By enhancing NO availability, NoNO-42 aims to improve endothelial function and reduce pathological inflammation in disease states.","oneSentence":"NoNO-42 is a nitric oxide (NO) donor compound designed to increase nitric oxide bioavailability in target tissues.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:23:17.456Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06403267","phase":"PHASE2","title":"NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy","status":"RECRUITING","sponsor":"NoNO Inc.","startDate":"2024-10-02","conditions":"Acute Ischemic Stroke","enrollment":600},{"nctId":"NCT06352632","phase":"PHASE3","title":"ACT-GLOBAL Adaptive Platform Trial for Stroke","status":"RECRUITING","sponsor":"The George Institute","startDate":"2024-09-26","conditions":"Stroke","enrollment":20000},{"nctId":"NCT05636306","phase":"PHASE1","title":"A Phase 1 Study to Evaluate Safety and Tolerability of NoNO-42 in Healthy Adults","status":"COMPLETED","sponsor":"NoNO Inc.","startDate":"2022-11-22","conditions":"First-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic Stroke","enrollment":83}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"NoNO-42","genericName":"NoNO-42","companyName":"NoNO Inc.","companyId":"nono-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}